FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Third Quarterly Performance Report Released for the 2017-2018 Fiscal Year
June 8, 2018

The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading


Take Control of Controlled Substances
May 7, 2018

Click Here to be in the know on how Florida’s new legislation on controlled substances affects you Continue reading